Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Ascension has agreed to acquire AmSurg, a ambulatory surgery business in Missouri, for $3 billion. Ascension acquisitions are aimed at scaling outpatient surgical capacity through AmSurg’s network of 250 ASCs and related ambulatory surgery services. The St. Louis-based strategic acquisition supports growth in ambulatory care and strengthens Ascension’s position among leading ASC operators. The healthcare M&A is structured as a platform acquisition and remains pending, with the strategic acquisition valued at over $100M and expected to close after regulatory review.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026